The CBD consumer product market is largely unregulated. Consumers have no way to be sure that the product they buy contains the ingredients listed on the label, and that it does not contain intoxicants or contaminants.
Journal Publishes Special Edition on Regulatory Responses to Opioid Poisoning Crisis
The Journal of Opioid Management (JOM) has published a special edition addressing legal and policy responses to the intertwined challenges of inadequate pain management and opioid misuse. Michael C. Barnes, Esq., Chairman of the Center for U.S. Policy, served as JOM’s Special Issue Editor.
What You Need to Know about Cannabinoid Law and Science
We, as consumers, need to be aware of the laws surrounding marijuana, CBD, and other cannabinoid products. Understanding these laws will allow us to make informed decisions based on the legality of cannabinoid products, and what we know about their safety.
There Is Another Drug Reform Bill the Senate Must Pass
S.3257 would facilitate access to treatment for opioid use disorder, which is essential amid the nationwide fentanyl poisoning crisis.